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Abstract 45	
We examined the effects of whey versus collagen protein on skeletal muscle cell signalling 46	
responses associated with mitochondrial biogenesis and protein synthesis in recovery from an 47	
acute training session completed with low carbohydrate (CHO) availability. In a repeated 48	
measures design (after adhering to a 36-h exercise-dietary intervention to standardise pre-49	
exercise muscle glycogen), eight males completed a 75-min non-exhaustive cycling protocol 50	
and consumed 22 g of a hydrolysed collagen blend (COLLAGEN) or whey (WHEY) protein 51	
45 min prior to exercise, 22 g during exercise and 22 g immediately post-exercise. Exercise 52	
decreased (P<0.05) muscle glycogen content by comparable levels from pre-to post-exercise 53	
in both trials (≈ 300 to 150 mmol.kg-1 dw). WHEY protein induced greater increases in 54	
plasma BCAAs (P=0.03) and leucine (P=0.02) than COLLAGEN.  Exercise induced 55	
(P<0.05) similar increases in PGC-1α (5-fold) mRNA at 1.5 h post-exercise between 56	
conditions though no affect of exercise (P>0.05) was observed for p53, Parkin and Beclin1 57	
mRNA. Exercise suppressed (P<0.05) p70S6K1 activity in both conditions immediately post-58	
exercise (≈ 25 fmol.min-1.mg-1). Post-exercise feeding increased p70S6K1 activity at 1.5 h 59	
post-exercise (P<0.05), the magnitude of which was greater (P <0.05) in WHEY (180 ± 105 60	
fmol.min-1.mg-1) versus COLLAGEN (73 ± 42 fmol.min-1.mg-1). We conclude that protein 61	
composition does not modulate markers of mitochondrial biogenesis when in recovery from a 62	
training session deliberately completed with low CHO availability. In contrast, whey protein 63	
augments post-exercise p70S6K activity compared with hydrolysed collagen, as likely 64	
mediated via increased leucine availability.  65	
Keywords: autophagy, p70S6K1, CHO restriction, glycogen 66	
 67	
 68	
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Introduction  69	
The role of increased dietary protein intake in facilitating skeletal muscle adaptations 70	
associated with endurance training is now gaining acceptance (Moore et al. 2014).  Indeed, 71	
consuming protein before (Coffey et al. 2011), during (Hulston et al. 2011) and/or after 72	
(Rowlands et al. 2015) an acute training session stimulates muscle protein synthesis 73	
(MPS).  Post-exercise protein feeding has also been shown to modify skeletal muscle 74	
transcriptome responses towards those supporting the endurance phenotype (Rowlands et al. 75	
2011).  In considering protein-feeding strategies for athletes, it is pertinent to consider the 76	
absolute dose (Moore et al. 2009; Witard et al. 2014; Rowlands et al. 2015; MacNaughton et 77	
al. 2016), feeding schedule (West et al., 2011; Areta et al. 2013), digestibility (Burke et al. 78	
2012; Phillips, 2016) and source of protein (Tang et al. 2009; Wilkinson et al. 2007).  79	
Contemporary guidelines recommend whey protein beverages due to its higher leucine 80	
content and rapid aminoacidemia upon ingestion (Thomas et al. 2016), though hydrolysed 81	
collagen beverages and gels are now commercially available and marketed to athletic 82	
populations. Whilst the use of a gel delivery matrix appears particularly beneficial for 83	
endurance athletes given the practical advantages of feeding while in locomotion (Impey et 84	
al. 2015), it is noteworthy that collagen based formulations likely have lower leucine content 85	
and digestibility compared with whey (Phillips, 2016). 86	
With this in mind, the aim of the present study was to therefore examine the effects of two 87	
practically relevant protein-feeding strategies (i.e. whey protein solution versus a hydrolysed 88	
collagen blend in a gel format) in modulating skeletal muscle cell signalling responses 89	
associated with mitochondrial biogenesis and MPS.  Given the increased popularity of 90	
training with low carbohydrate (CHO) availability (i.e. the train-low paradigm) in an attempt 91	
to enhance mitochondrial related adaptations (Hawley and Morton, 2014; Bartlett et al. 2015; 92	
Impey et al. 2016; 2018), we adopted an experimental design whereby male cyclists 93	
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completed a non-exhaustive training session in which glycogen remained within an absolute 94	
concentration (i.e. pre-and post-exercise concentrations of <350 and >100 mmol.kg dw-1, 95	
respectively) considered representative of train-low conditions (Impey et al. 2018).   96	
 97	
Methodology  98	
Subjects: After providing informed written consent, eight recreational male cyclists (age: 25 99	
± 3 years; height: 175 ± 0.1 cm; body mass: 74.4 ± 6.7 kg) who trained between 3 – 10 hours 100	
per week took part in this study. Mean VO2peak and peak power output (PPO) was 56.5 ± 3.8 101	
ml.kg-1.min-1 and 327 ± 26 W respectively. None of the participants had a history of 102	
neurological disease or skeletal muscle abnormality and none were under pharmacological 103	
intervention during the study. The study was approved by the Research Ethics Committee of 104	
Liverpool John Moores University.  105	
Design: In a repeated measures counterbalanced design separated by 7-9 days, subjects 106	
completed two non-exhaustive acute exercise trials in conditions of reduced CHO availability 107	
with whey (WHEY) or a hydrolysed collagen blend (COLLAGEN) provision before, during 108	
and after exercise. At 36-40 h prior to the main experimental trials, all subjects performed a 109	
glycogen depletion protocol followed by 36 h of low CHO (3 g.kg.d-1) and energy intake 110	
(~7.58 ± 0.6 MJ.day-1) (as replicated from Impey et al. 2016) in order to standardise pre-111	
exercise muscle glycogen content (see Figure 1). Subjects refrained from CHO intake on the 112	
morning of the main experimental trial as well as during exercise, but consumed 1.2 g/kg 113	
body mass (BM) of CHO split across two equal 0.6 g/kg doses at 30 min and 60 min post 114	
exercise in both trials.  Subjects consumed 22 g of whey or collagen protein at 45 minutes 115	
prior to exercise, 22 g during exercise and a further 22 g immediately post-exercise. Both 116	
trials represented deliberate conditions of reduced CHO and absolute energy availability, but 117	
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with high protein availability in the form of whey or collagen throughout. Muscle biopsies 118	
were obtained from the vastus lateralis immediately pre-, post- and at 1.5 h post-exercise.  119	
Assessment of peak oxygen uptake: Participants were assessed for peak oxygen consumption 120	
(VO2peak) and peak aerobic power (PPO) as determined during an incremental cycle test 121	
performed on an electromagnetically braked cycle ergometer as previously described (Impey 122	
et al. 2015).  123	
Experimental Protocol: 124	
Day 1 and 2: Participants arrived at the laboratory on the evening (17.00) of day 1. Subjects 125	
then performed an intermittent glycogen-depleting cycling protocol lasting ~120 min ( as 126	
described by Impey et al. 2016). This protocol and all subsequent cycling protocols were 127	
conducted on a fully adjustable electromagnetically braked cycle ergometer (Lode Excalibur, 128	
Netherlands). The activity pattern and total time to exhaustion (115 ± 5 min; Energy 129	
expenditure: 1444 ± 107 kJ) were recorded and repeated exactly during the second 130	
experimental condition. Participants then consumed a diet low in carbohydrate (3 g.kg-1 BM) 131	
but high in protein (2 g.kg-1 BM) over the next 36 h to minimise muscle glycogen 132	
replenishment to ~300-350 mmol.kg-1 dw on the morning of the main experimental trial.  133	
During this 36 h period prior to the main experimental trial, total energy intake equated to 134	
7.58 ± 0.6 MJ.  Estimated energy expenditure (as calculated from resting metabolic rate using 135	
the Harris Benedict equation and PAL level of 1.4 for the sedentary period on Day 2) was 15. 136	
9 ± 1.1 MJ and hence energy balance was – 8.4 ± 0.45 MJ. 137	
Day 3: Subjects reported to the laboratory in a fasted state and an indwelling cannula (Safety 138	
Lock 22G, BD Biosciences, West Sussex UK) was inserted into the anticubital vein in the 139	
anterior crease of the forearm.  Blood samples were collected immediately prior to and every 140	
15 minutes during exercise as well as at 30 minute intervals in the recovery period from 141	
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exercise. Subjects consumed 22 g of protein from one of two commercially available 142	
products consisting of a hydrolysed collagen blend in a gel format (COLLAGEN: Muscle 143	
Gel, Muscle Pharm, USA; Ingredients: water, hydrolysed collagen, whey protein isolate, 144	
dietary fibre, natural flavours, citric acid, ascorbic acid, malic acid, niacinamide, sodium 145	
benzoate, potassium sorbate, sucralose, calcium D pantothenate, pyridoxine HCL, riboflavin) 146	
or a whey protein solution (WHEY: Whey Protein, Science in Sport, Nelson, UK; 147	
Ingredients: whey protein concentrate, whey protein isolate, fat reduced cocoa powder, 148	
natural flavourings, xanthan gum, soy lecithin, sucralose) at 45 minutes prior to beginning 149	
exercise. Due to the clear differences in delivery methods of protein sources (i.e. gel versus 150	
solutions), neither single nor double blinding of treatments occurred.  Fluid intake was 151	
matched in both conditions to 500 ml at this time-point. Subjects then rested for 45 minutes 152	
prior to commencing exercise. Protein was given 45 min prior to exercise in an attempt to 153	
maintain elevated circulatory amino acid availability during the exercise protocol (Impey et 154	
al. 2015). Following a 5 min warm up at 150 W, subjects then completed a prescribed cycling 155	
protocol consisting of 4 x 30 seconds high intensity intervals at 200% PPO interspersed with 156	
2.5 min active recovery at 40% PPO, followed by 45 min steady state cycling at 60% PPO 157	
and finally, 3 x 3min intervals at 90% PPO. During the HIT and steady state component, 158	
subjects ingested 7.3g of COLLAGEN or WHEY protein every 20 min to provide 22 g of 159	
protein per hour.  Physiological and perceptual measures were recorded at regular intervals 160	
throughout exercise (e.g. heart rate, RPE) and substrate utilisation was assessed during the 161	
steady state component of the exercise protocol using online gas analysis (CPX Ultima, 162	
Medgraphics, Minnesota, US) according to Jeukendrup and Wallis (2005).  Following 163	
completion of the training session, subjects consumed an additional 22 g of COLLAGEN or 164	
WHEY protein immediately post-exercise as well as 1.2g.kg-1 BM carbohydrate in the form 165	
of sports drinks (Science in Sport, Nelson, UK) and snacks (Jaffacakes, UK) split as equal 166	
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doses of 0.6 g.kg-1 BM at 30 and 60 minutes post-exercise. Laboratory conditions remained 167	
constant across all experimental trials (19 – 21oC, 40 – 50% humidity). 168	
Muscle biopsies: Muscle biopsies were obtained from separate incision sites (2 – 3 cm apart) 169	
from the lateral portion of the vastus lateralis muscle. Biopsies were obtained using a Bard 170	
Monopty Disposable Core Biopsy Instrument (12 guage x 10 cm length, Bard Biopsy 171	
Systems, Tempe, AZ, USA). Samples were obtained under local anaesthesia (0.5% marcaine) 172	
and immediately frozen in liquid nitrogen and stored at – 80oC for later analysis.  173	
Blood analysis: Blood samples were collected in vacutainers containing K2 EDTA, lithium 174	
heparin or serum separation tubes, and stored on ice or at room temperature until 175	
centrifugation at 1500 g for 15 min at 4 ̊C. Serum and plasma were aliquoted and stored at -176	
80 ̊C until analysis. Plasma glucose, lactate, non-esterifed fatty acids (NEFA), glycerol, β-177	
hydroxybutyrate (β-OHB), insulin and amino acids were analysed as previously described 178	
(Impey et al. 2016).  179	
RNA extraction and analysis and Reverse transcriptase quantitative Real-Time 180	
Polymerase Chain Reaction (rt-qRT-PCR): Muscle samples (~ 20 mg) were immersed and 181	
homogenized in 1ml TRIzol (Thermo Fisher Scientific, UK). RNA was extracted according 182	
to the manufacturer’s instructions. RNA concentration and purity were assessed by UV 183	
spectroscopy at ODs of 260 and 280 nm using a Nanodrop 3000 (Fisher, Rosklide, 184	
Denmark). 70 ng RNA was used for each PCR reaction. Primer were purchased from Sigma 185	
(Suffolk, UK) and forward (F) and reverse (R) sequences were as follows: PGC-1 (F: 186	
TGCATGAGTGTGTGCTCTGT; R: CAGCACACTCGATGTCACTC), p53 (F: 187	
ACCTATGGAAACTACTTCCTGAAA; R: CTGGCATTCTGGGAGCTTCA), Parkin (F: 188	
TCCCAGTGGAGGTCGATTCT; R: GGAACCCCCTGTCGCTTAG), Beclin1 (F: 189	
ATCTCGAGAAGGTCCAGGCT; R: TCTGGGCATAACGCATCTGG). rt-qRT-PCR 190	
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amplifications were performed using QuantiFastTM SYBR® Green RT-PCR one step kit on a 191	
Rotogene 3000Q (Qiagen, Crawley, UK) supported by rotogene software (Hercules, CA, 192	
USA).  Detailed procedures are described by Impey et al. (2016).  193	
Muscle glycogen concentration: Muscle glycogen concentration was determined from 10-194	
20 mg muscle tissue according to the acid hydrolysis method described previously (Impey et 195	
al. 2016). Glucose concentrations were quantified using a commercially available kit (GLUC-196	
HK, Randox Laboratories, Antrim, UK).  197	
[γ-32P] ATP Kinase Assay: Twenty mg muscle tissue was used for the measurement of 198	
p70S6K1 and PKB (Akt) activity as previously described (McGlory et al. 2014). 199	
Statistics: Statistical analyses were performed using Statistical Package for the Social 200	
Scientist (SPSS version 21). Changes in physiological and molecular responses between 201	
conditions (i.e. muscle glycogen, circulatory metabolites, amino acids, mRNA and kinase 202	
activity) were analysed using two way repeated measures General Linear Model, where the 203	
within factors were time and condition. Where a significant main effect was observed, 204	
pairwise comparisons were analysed according to Bonferoni post hoc tests in order to locate 205	
specific differences. A P value < 0.05 was deemed significant and all data in text, figures and 206	
tables are presented as mean ± SD. 207	
 208	
Results  209	
Physiological and metabolic responses to exercise 210	
Exercise intensity and substrate metabolism during the steady state component of the exercise 211	
protocol is displayed in Table 1. No significant differences (P>0.05) were observed between 212	
trials for any parameter.  Exercise reduced (P<0.001) muscle glycogen stores to comparable 213	
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levels (150 mmol.kg-1 dw) with no difference (P=0.485) between conditions (Table 2).  214	
Plasma NEFA, glycerol and β-OHB increased during exercise (P<0.001) though plasma 215	
glucose did not display any change (P = 0.112) (Figure 2 A, B, C and D, respectively). 216	
Changes in plasma NEFA availability across the whole sampling period were suppressed in 217	
WHEY compared with the COLLAGEN trial (P=0.046) whereas no differences were 218	
observed between trials for glycerol (P=0.080), β-OHB (P = 0.070) or glucose (P=0.963).  219	
Despite differences in NEFA availability during exercise, no differences were observed in 220	
either CHO (P=0.640) or lipid oxidation (P=0.750) during the steady state component of the 221	
exercise protocols (Table 1, respectively). 222	
Markers of mitochondrial adaptations 223	
The magnitude of the exercise-induced increase (P = 0.001) in PGC-1α mRNA expression at 224	
90 min post-exercise was not different (P = 0.731) between trials (Figure 3A). Neither 225	
exercise (P = 0.354) nor experimental condition (P = 0.472) affected p53 mRNA expression 226	
(Figure 3B).  As markers of mitophagy, Parkin mRNA displayed no effect of exercise (P = 227	
0.417) or experimental condition (P = 0.301), whereas Beclin 1 displayed a trend towards an 228	
effect of exercise (P = 0.058) but no effect of condition (P = 0.968).   229	
 230	
Plasma amino acids, serum insulin and p70S6K1 related signalling 231	
Plasma leucine, BCAAs and EAAs all displayed a significant main effect of time (P=0.043, 232	
0.028 and 0.021, respectively) during the sampling period (Figure 4 A, B, C respectively).  233	
Pairwise comparisons demonstrated that leucine and BCAAs were significantly different 234	
from pre-exercise after 30 and 45 minutes of exercise and that BCAAs were also different 235	
from pre-exercise values after 30, 60 and 90 minutes of recovery.  Such main effects of time 236	
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appear to be predominantly due to those changes occurring in the WHEY trial given that no 237	
differences are apparent in the COLLAGEN trial.  Additionally, leucine (P=0.02) and BCAA 238	
concentrations (P=0.03) also demonstrated a main effect for condition such that WHEY was 239	
greater than COLLAGEN whereas differences in EAA between trials only approached 240	
statistical significance (P=0.060). When expressed as AUC data, only plasma leucine 241	
(P=0.025) was different between trials whereas AUC for BCAA (P=0.135) and EAA 242	
(P=0.062) were not different (data not shown).   243	
In accordance with post-exercise CHO intake, insulin increased from pre- and post-exercise 244	
values (P = 0.034) though the magnitude of change was not different between trials (P = 245	
0.159) (Figure 4D).  As such, no difference (P=0.187) was apparent between trials for insulin 246	
AUC data (data now shown) 247	
PKB activity was elevated at 90 min post-exercise (P = 0.003) compared with pre-exercise 248	
values, irrespective of nutritional condition (P=0.370) (Figure 4E). Exercise suppressed 249	
(P=0.015) p70S6K activity to comparable levels immediately post-exercise (≈ 25 fmol.min-250	
1.mg-1).  However, post-exercise feeding increased p70S6K activity at 1.5 h post-exercise 251	
(P=0.004), the magnitude of which was greater (P=0.046) in WHEY (180 ± 105 fmol.min-252	
1.mg-1) versus COLLAGEN (73 ± 42 fmol.min-1.mg-1) (Figure 4F).   253	
 254	
Discussion  255	
We examined the effects of whey versus collagen protein on skeletal muscle cell signalling 256	
responses associated with mitochondrial biogenesis and protein synthesis in recovery from an 257	
acute training session completed with low CHO availability. We deliberately studied two 258	
forms of protein feeding that we consider have practical relevance for endurance athletes i.e. 259	
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a whey protein solution versus a hydrolysed collagen blend administered in a gel format.  We 260	
also adopted an acute training session intended to mimic situations in which endurance 261	
athletes deliberately train with low endogenous and exogenous CHO availability in an 262	
attempt to promote oxidative training adaptations (Impey et al. 2018).  Whilst we observed no 263	
effects of protein composition on acute adaptations associated with mitochondrial biogenesis, 264	
whey protein induced greater leucinemia and post-exercise activity of p70S6K activity than 265	
collagen. 266	
In accordance with the well-documented differences in amino acid composition between 267	
whey and collagen (Castellanos et al. 2006), we observed marked differences in the extent of 268	
leucinemia induced by the two protein feeding strategies.  In this regard, leucine was elevated 269	
to a greater extent with the whey protein solution when compared with the hydrolysed 270	
collagen gel format.  In agreement with previous reports from our laboratory (Taylor et al. 271	
2013) and others (Breen et al. 2011), we observed that amino acid availability does not 272	
apparently modulate acute markers of mitochondrial adaptations.  In contrast, we observed 273	
whey protein induced greater increases in post-exercise p70S6K activity.  The effects of post-274	
exercise whey protein consumption on activation of the mTOR-p70S6K pathway is well 275	
documented (Phillips, 2016) and hence, the greater effect of whey compared with collagen on 276	
activation of p70S6K is likely related to the increased leucine availability (Moberg et al. 277	
2014; Apro et al. 2015a). Nonetheless, we acknowledge that direct assessment of muscle 278	
protein synthesis using stable isotope or deuterium methods would have provided greater 279	
insight to the functional relevance of the nutritional strategies used here.  In addition, future 280	
studies could also assess if such divergent signalling responses are still apparent if the 281	
collagen formulation was fortified with additional leucine content to match that of the whey 282	
solution. 283	
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Although we readily acknowledge that the total leucine delivery in the WHEY trial may 284	
appear excessive in terms of that required to facilitate protein synthesis as well as likely 285	
resulting in elevated leucine oxidation (as suggested by the fall in leucine and BCAA after 30 286	
and 45 minutes of exercise), we deliberately chose this dosing strategy for a number of 287	
practical reasons. Firstly, given that exercising in CHO restricted states augments leucine 288	
oxidation (Lemon and Mullin, 1980; Wagenmakers et al. 1991; Howarth et al. 2009), it was 289	
our deliberate aim to administer higher exogenous leucine so as to deliver both substrate to 290	
promote muscle protein synthesis (Breen et al. 2011; Pasiakos et al. 2011; Churchward-291	
Venne et al. 2013) but yet, also compensate for the higher levels of endogenous leucine 292	
oxidation (Lemon and Mullin, 1980; Howarth et al. 2009).  Second, unpublished observations 293	
by the corresponding author on elite professional cyclists indicated that this is the type of 294	
protein feeding strategy actually adopted during morning training rides that are deliberately 295	
undertaken in the absence of CHO intake before and during exercise.  As such, our aim was 296	
to replicate these “real world” strategies and determine the effects of such high protein 297	
availability on substrate metabolism and post-exercise signalling responses.  Finally, given 298	
that many elite cyclists are potentially in daily energy deficits (Vogt et al. 2005) with low 299	
energy availability (Loucks et al. 2011), and also that 3 g/kg body mass of daily protein has 300	
been recommended to maintain lean mass during energy restriction (Stokes et al. 2018), we 301	
therefore considered this feeding strategy to be in accordance with daily protein intakes for 302	
both quantity and frequency (Areta et al. 2013).  For example, over the 3.5 h data collection 303	
period (i.e. 9 am to 1230 pm), the present subjects (ranging from 70-80 kg) consumed 66 g 304	
protein and hence for the daily target to be achieved (i.e. approximately 210-240 g), our 305	
approach is therefore in accordance with a feeding strategy where subsequent 30-40 g doses 306	
could be consumed at 3 h intervals (e.g. 1, 3, 6 and 9 pm if required). 307	
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When considered in combination with our recent data (Impey et al. 2016; Hammond et al. 308	
2016), the present study also adds to our understanding of the regulation of p70S6K activity 309	
both during and after exercise.  Indeed, whereas other researchers have reported that acute 310	
endurance exercise does not suppress post-exercise p70S6K phosphorylation (Coffey et al. 311	
2006) or activity (Apro et al. 2015b), we have consistently observed an exercise-induced 312	
suppression in p70S6K activity. We suggest that such differences between studies may be 313	
due to the magnitude of energy deficit associated with the CHO restriction and glycogen 314	
taxing exercise protocols used both here and previously (Impey et al. 2016).  Indeed, whilst it 315	
is difficult to directly compare the total energy expenditure between this study and the data of 316	
Apro et al. (2015b), the exercise intervention studied here elicited considerably lower muscle 317	
glycogen concentrations (i.e. ~150 mmol.kg-1dw vs 350 mmol.kg-1dw).  The potential effects 318	
of low muscle glycogen availability on post-exercise signalling (albeit in response to 319	
resistance exercise) was also evidenced by Camera et al. (2012) who observed that low 320	
muscle glycogen availability (i.e. 150-200 mmol.kg-1dw) reduced mTOR phosphorylation 321	
compared with higher glycogen concentration (i.e. 350-400 mmol.kg-1dw). Nonetheless, 322	
these workers also observed the apparent disconnect between snapshots of cell signalling and 323	
functional outcomes given that glycogen concentrations did not affect myofibrillar protein 324	
synthesis. 325	
In relation to the re-activation of p70S6K activity in the recovery period from exercise, it is 326	
noteworthy that we previously observed that the sustained presence of reduced CHO (and 327	
energy availability) and/or high post-exercise fat availability also suppresses the re-activation 328	
of p70S6K1, even when leucine enriched whey protein was consumed in the post-exercise 329	
period (Impey et al. 2016).  Based on these studies, we therefore suggested that the apparent 330	
suppression of p70S6K1 activity may be due to 1) reduced insulin and PKB signalling or, 2) 331	
a direct effect of increased fat availability (Kimball et al. 2015) and/or reduced glycogen 332	
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mediating suppression of mTORC1 complex via energetic stress related mechanisms. The 333	
present data lend support for the latter mechanism for several reasons.  First, we observed 334	
that the whey-induced increase in p70S6K1 activity when compared with collagen feeding 335	
was independent of post-exercise insulin and PKB activity.  Second, at the termination of 336	
exercise (i.e. the 75 min time point that corresponds low muscle glycogen availability and 337	
energy deficit) the absolute circulating NEFA concentrations observed in our collagen trial 338	
(i.e. approximately 1.5 mmol.L-1) was similar to that achieved with both CHO restriction 339	
(Impey et al. 2016) and post-exercise high fat feeding protocols (Hammond et al. 2016). The 340	
apparent suppression of NEFA in the WHEY trial may be due to the higher insulin responses 341	
associated with feeding whey protein before and during exercise (Impey et al. 2015; Taylor et 342	
al. 2013), thereby causing a reduction in lipolysis that manifests itself as reduced circulating 343	
NEFA availability during the exercise period.  Nonetheless, we acknowledge that the current 344	
assessments of insulin concentration were limited to pre-and post-exercise time-points per se.  345	
We also acknowledge the limitations associated with making inferences on muscle free fatty 346	
acid (FFA) uptake on snapshot assessments of circulating NEFA per se.  Nonetheless, given 347	
recent data demonstrating that acute increases in fat availability (as achieved via lipid 348	
infusion protocols) impairs MPS in human skeletal muscle despite similar circulating insulin 349	
and leucine concentrations (Stephens et al. 2015), it remains possible that subtle alterations in 350	
FFA availability (as caused by “acute” dietary manipulations) can have associated 351	
implications on mTOR related signalling.  When considered with previous studies (Impey et 352	
al. 2016; Hammond et al. 2016), the present data suggest that in those exercise conditions in 353	
which muscle glycogen is near depletion, the beneficial effects of whey protein (i.e. leucine 354	
mediated activation of mTOR) are especially apparent when co-ingested with post-exercise 355	
CHO feeding. Whilst there may be benefits of commencing training with reduced 356	
endogenous and exogenous CHO availability, we suggest the post-exercise meal should 357	
15	
	
	
contain a combination of both protein and CHO, the latter to provide the necessary substrate, 358	
energy and metabolic environment to stimulate cell signalling processes.  359	
In summary, we demonstrate that when in recovery from an acute training session undertaken 360	
with low CHO and energy availability, whey protein induces greater leucinemia and post-361	
exercise p70S6K activity compared with a hydrolysed collagen blend. Data suggest that 362	
hydrolysed collagen blends are a sub-optimal protein source in relation to the goal of 363	
stimulating those signalling pathways that regulate muscle protein synthesis. Future studies 364	
are now required to directly assess the acute effects of whey versus collagen protein feeding 365	
on muscle protein synthesis as well as to examine the long-term effects of such feeding 366	
strategies on training-induced skeletal muscle adaptations and performance outcomes. 367	
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 518	
Figure 1. Schematic representation of the experimental design. On the evening of day 1, 519	
subjects completed a glycogen depleting protocol followed by consumption of 22 g of whey 520	
protein. Throughout the entirety of day 2, subjects consumed a low CHO and low energy 521	
dietary protocol that was matched for both protein and fat intake. During the main 522	
experimental trial on day 3, subjects ingested 22 g of collagen (COLLAGEN) or whey 523	
(WHEY) protein before, during and after completion of an acute train-low exercise protocol. 524	
In addition to protein, subjects also consumed CHO (0.6 g.kg-1 BM) at 30 min and 1 h post-525	
exercise. Muscle biopsies were obtained immediately pre-exercise, post-exercise and 1.5 h 526	
post-exercise.  This experimental protocol represents an amalgamation of train-low 527	
paradigms as subjects effectively performed sleep low on the evening of day 1, consumed a 528	
low CHO diet on day 2 and finally, completed an acute training session on the morning of 529	
day 3 with CHO restricted before and during exercise. 530	
 531	
22	
	
	
Figure 2. Plasma (A) NEFA, (B) glycerol, (C) βOHB and (D) Glucose during and in 532	
recovery from exercise. Shaded area represents exercise duration. * P<0.05 significant 533	
difference from pre-exercise (i.e. time-point 0), ^ P<0.05 significant main effect of condition.  534	
 535	
Figure 3. mRNA expression of (A) PGC-1α, (B) p53, (C) Parkin and (D) Beclin1. * P<0.05 536	
significant difference from pre-exercise. 537	
 538	
Figure 4. Plasma (A) leucine, (B) total BCAA, (C) total EAA and (D) insulin.  Kinase 539	
activity of (E) PKB and (F) p70S6K. Shaded area represents exercise duration. *P<0.05 540	
significant difference from pre-exercise, **P<0.05 significant difference from post-exercise, 541	
^P<0.05 significant main effect of condition.  542	
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 580	
Table 1 – Exercise intensity and substrate metabolism during the steady state component of the 581	
exercise protocol. 582	
 583	
 584	
 585	
 586	
 587	
 588	
 589	
 590	
 591	
 592	
 593	
 594	
 595	
 596	
 597	
 598	
 599	
 600	
 601	
 602	
                                                     
                                             Time (min) 
 15 30 45 
    
VO2 (% VO2max)    
WHEY 66 ± 1 67 ± 2 68 ± 2 
COLLAGEN 67 ± 2 67 ± 1 68 ± 1 
Heart Rate (b.min-1)    
WHEY 165 ± 12 167 ± 12 166 ± 12 
COLLAGEN 167 ± 6 168 ± 8 168 ± 8 
RER (AU)    
WHEY 0.86 ± 0.05 0.86 ± 0.05 0.86 ± 0.06 
COLLAGEN 0.86 ± 0.05 0.87 ± 0.03 0.86 ± 0.03 
CHO Oxidation (g.min-1)    
WHEY 1.9 ± 0.8 1.9 ± 0.8 1.9 ± 0.9 
COLLAGEN 2.1 ± 0.6 2.1 ± 0.6 2.1 ± 0.6 
Lipid Oxidation (g.min-1)    
WHEY 0.7 ± 0.4 0.7 ± 0.3 0.7 ± 0.4 
COLLAGEN   0.6 ± 0.2           0.6 ± 0.2     0.7 ± 0.2  
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Table 2 – Muscle glycogen concentration before and after exercise. * denotes significant different 603	
from pre-exercise, P<0.05. 604	
 605	
 606	
 607	
 608	
 609	
 610	
 611	
 612	
 613	
 614	
 615	
 616	
 617	
                                                     
                                             Time (min) 
 Pre- Post- + 90 min 
    
Glycogen (mmol.kg-1 dw)    
WHEY 339 ± 66 158 ± 80 * 183 ± 35 * 
COLLAGEN 356 ± 44 141 ± 25 * 173 ± 23 * 
    
